NUTEX HEALTH REPORTS FOURTH QUARTER AND FULL YEAR 2024 FINANCIAL RESULTS

FULL YEAR 2024 HIGHLIGHTS: TOTAL REVENUE OF $479.9 MILLION VERSUS $247.6 MILLION IN 2023, AN INCREASE OF 93.8% NET INCOME OF $52.2 MILLION VERSUS NET LOSS OF $45.8 MILLION IN 2023 DILUTED EPS OF $9.71 PER SHARE VERSUS $(10.39) PER SHARE IN 2023 EBITDA OF $98.4 MILLION VERSUS $(22.5) MILLION IN EBITDA IN 2023 ADJUSTED…

Read More

NUTEX HEALTH RESCHEDULES EARNINGS RELEASE AND CONFERENCE CALL

HOUSTON, March 27, 2025 — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX) announced that it has rescheduled the release of its financial results and conference call related to the fourth quarter and full year ended December 31, 2024, which had previously been scheduled for March 27, 2025 and March 28, 2025, respectively.…

Read More

Nutex Health to Present at the EDPMA Solutions Summit 2025

HOUSTON, March 20, 2025 — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro-hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced its CEO, Dr. Tom Vo, will present at the EDPMA Solutions Summit 2025. This event will take place…

Read More

NUTEX HEALTH SCHEDULES 2024 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS RELEASE AND CONFERENCE CALL

HOUSTON, March 17, 2025 — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 24 state-of-the-art micro hospitals in 11 states and primary care-centric, risk-bearing physician networks, today announced that it will release financial results for the fourth quarter and year ended December 31, 2024 after…

Read More